Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Gastroenterology
Disease Category: Colon Cancer
Trial Information
ECOG N0147, A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer
Find out if adding cetuximab to FOLFOX (a combination of the 3 drugs oxaliplatin, leucovorin and 5-fluorouracil) increases the effectiveness of FOLFOX in preventing your colon cancer from coming back.
See whether patients get better results in one of these groups. Compare the side effects in the two groups of patients in the study. We will look at markers in tissue or blood specimens obtained from you to determine whether these markers can be used to predict whether your tumor responds to chemotherapy or the chance that your cancer will come back. These studies are for research purposes and have not been accepted into routine medical practice.
Patient Inclusion Criteria:
- Eligible subjects will be identified and recruited from within the practice populations of participating physicians. There will be no direct patient solicitation employed by local sites participating in this trial. Several Internet sites have objective information regarding this trial and participating sites, but this information is not an advertisement tool for soliciting subjectsAge>18
- Zubrod performance 0-2
- Able and willing to complete questionnaires
Patient Exclusion Criteria: Pregnant women are excluded from the study because agents used in this study may lead to developmental abnormalities in a fetus. Lactating women are excluded because there is no
information on the excretion of the agents or their metabolites into breast milk.
Janeen V Bazan, RN, Oncology Research Nurse Program Coordinator
Sherman Health Systems
934 Center Street
Elgin, Il 60120
Phone: 847 429 2907
Fax: 847 429 3071
EMail: janeen.bazan@shermanhospital.org
View Google Map
Research Center Information: Sherman Health Systems
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
